WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'4101 Infant (under 12 months) mortality rate: 272
GDP / capita (US$): 14'6941 Child (under 5 years) mortality rate: 322

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 36'423  35'273  34'107  32'958  31'868  23'575  17'478  13'653 
Births 1'244  1'219  1'193  1'165  1'136  838  664  545 
Surviving infants 1'206  1'181  1'155  1'127  1'099  808  639  518 
Pop. less than 5 years 5'727  5'594  5'456  5'307  5'140  3'841  3'006  2'435 
Pop. less than 15 years 14'927  14'515  14'102  13'696  13'302  10'129  8'020  6'395 
Female 15-49 years 8'841  8'558  8'260  7'957  7'670  5'604  3'834  2'793 

Number of reported cases

(Click for retrospective incidence data for Iraq)
Diphtheria
ChartChart
  34  10  1'122 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  1'433  1'317  669  15  15  726  3'045  26'542 
Mumps
ChartChart
  12'957  1'295  1'809  1'482  1'944  18'720 
Pertussis
ChartChart
  529  1'606  2'471  2'314  2'019  407  122  16'687 
Polio*
ChartChart
  56  997 
Rubella
ChartChart
  30  22  18  1'612 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  11  10  37  152  891 
Tetanus (total)**
ChartChart
  31  34  34  39  1'045 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Iraq)
Vaccine year result method % card seen                                                
BCG 2010  90  MICS   70  80  91  93  99*  69  79  95  76 
DTP1 2010  86  MICS   70  80  84  89  95  97  92  91 
DTP3 2010  70  MICS   70  68  74  78  79  89  86  83  13 
DTP4          70  59 
IPV1         
HepB_BD          43  43  43  37  79 
HepB3 2010  66  MICS   70  68  74  78  73  89  67 
Hib3          68  74  78  46 
JapEnc         
MCV1          71  71  77  83  91  93  83  35 
MCV2          76  76  71  82  91 
PCV1         
PCV3         
Pol3 2010  76  MICS   70  72  76  79  79  89  86  83  16 
Rota1          55  60  68  65 
RotaC          34  51  52  31 
Rubella1          76  76  71  82  91 
TT2plus 2010  29  MICS   70  34  49  59  66  75  55  63 
PAB         
VAD1          59  60  67  17  66  49 
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Iraq)
BCG
ChartChart
  95  97  95  92  93  96  76 
DTP1
ChartChart
  77  82  87  90  92  93  36 
DTP3
ChartChart
  64  68  69  79  80  83  14 
HepB3
ChartChart
  62  66  61  77  67 
HepB_BD
ChartChart
  43  43  37  32 
Hib3
ChartChart
  64  68  36 
MCV1
ChartChart
  57  63  69  77  86  75 
MCV2
ChartChart
  57  57  68  77 
PAB
ChartChart
  72  72  85  85  75  70 
PCV3
ChartChart
 
Pol3
ChartChart
  67  70  70  80  83  83  16 
RotaC
ChartChart
  29  52  31 

Number of districts in the country 135  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
90 
   
/
|
|
\
Greater or equal to 90% 22
From 80 to 89% 14
From 50 to 79% 41
Less than 50% 19
Proportion of districts
not reporting DTP3 coverage
4
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes <12 months
DT 2, 4, 6, 18 months; 4-6 years; Yes
DTaPHibHepIPV 2, 4, 6 months; Yes From January 2016
DTwPHib 4, 18 months; 4-6 yearrs; Yes
DTwPHibHepB 2, 6 months; Yes
HepB birth; Yes high risk groups
IPV 2, 4, 6, 18 months Yes
Influenza Yes Children, elderly, chronic illness, pregnant women, health care workers, Haj or other travellers
MMR 18 months; Yes
Measles 9 months; Yes
MenC_conj Yes high risk groups
OPV birth; 2, 4, 6, 18 months; 4-6 years; Yes
Pneumo_conj No High risk group
Pneumo_ps Yes high risk group
Rotavirus 2, 4, months; Yes
TT 1st contact; +1, +6 months; +1, +1 years; Yes CBAW
Td >6 years; Yes CBAW
Typhoid Yes high risk adults
YF Yes immigrants to africa

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2017  2012-2017  2012-2017  2010-2014  2009-2014  2010-2114  2009 - 2013 
Nº of districts with microplans that include activities to raise immunization coverage number 135  133    129    72  114 

System performance

Total Nº districts in country number 135  133  130  129  125  121  115 
Nº districts with DTP3 coverage >=80% number 54  68  65  98  73  73  70 
% of districts with DTP3 coverage >=80% From 0 to 100% 40  51  50  76  58  60  61 
Nº districts with measles (MCV1) coverage >=95% number 21  15  23  37  39  50  50 
% of districts with MCV1 coverage >=95% From 0 to 100% 16  11  18  29  31  41  43 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  No       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes    Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 90  100        98  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.